FDA Inspection
Novartis Pharma Stein AGNovartis Pharma Stein AG – FDA Inspection, Dec 6, 2022
Record Details
This FDA Inspection record concerns Novartis Pharma Stein AG, with an inspection on December 6, 2022, issued by the Center for Drug Evaluation and Research, covering drugs.
- Company
- Novartis Pharma Stein AG
- Inspection Date
- December 6, 2022
- Product Type
- Drugs
View Company Profile
ID · 5994d6f5-291c-4a32-87bf-4376f992a6bb
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1192104
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
Other FDA inspections of Novartis Pharma Stein AG
13| Date | Classification | Office | Project area |
|---|---|---|---|
| May 19, 2026 | Not classified | Office of Inspections and Investigations | Human Cellular, Tissue, and Gene Therapies |
| November 20, 2023 | Not classified | Office of Inspections and Investigations | |
| December 4, 2018 | VAI | Center for Biologics Evaluation and Research | Vaccines and Allergenic Products |
| September 21, 2018 | Not classified | Office of Inspections and Investigations | |
| August 24, 2017 | Not classified | Office of Inspections and Investigations |
Other documents for Novartis Pharma Stein AG
- FDA Inspection 1319902 - 2026-05-19
- FDA Inspection 1230809 - 2023-11-20
- FDA Inspection 1073408 - 2018-12-04
- FDA Inspection 1071638 - 2018-09-21
- FDA Inspection 1025563 - 2017-08-24
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.